INTERLEUKIN-6 (-597G/A) POLYMORPHISM IN EGYPTIAN HEPATITIS C-VIRUS INFECTED PATIENTS

Synergistic Effect of Schistosomiasis on Hepatitis C Virus (HCV) of Human Liver Indicated by Antioxidant Biomarkers among Egyptian Population

The role of interleukin-2 and interleukin-4 in disease progression in patients with schistosomiasis combined with chronic viral hepatitis C and chronic viral hepatitis B

INTERLEUKIN 28B GENE POLYMORPHISMS AS A PREDICTOR OF TREATMENT RESPONSE IN EGYPTIANS WITH CHRONIC HEPATITIS C.

IN VIVO AND IN VITRO EXPRESSIONS OF CCR1 AND CCR5 IN PATIENTS WITH ACTIVE SCHISTOSOMIASIS AND CHRONIC LIVER DISEASE

Genetic Variants in ITPA and TNFSF10A Are Associated with the Risk of HCV Infection Among Egyptian Populations

Immunoparasitological Study in Bilharzial Patients With or without Hepatitis C Virus in El-Beheira Governorate

AN INITIAL INDICATION OF PREDISPOSING RISK OF SCHISTOSOMA MANSONI INFECTION FOR HEPATOCELLULAR CARCINOMA

Biochemical and Histopatholigcal changes in Egyptian patients with Hepatitis C and Bilharziasis.

EVIDENCE OF ANTI-DOUBLE STRANDED DNA ANTIBODIES AND C-REACTIVE PROTEIN IN EGYPTIAN PATIENTS WITH HIGH ANTI-SCHISTOSOMA MANSONI ANTIBODY TITER